最新报道:A contrarian fund outperforming 97% of peers is accumulating healthcare stocks, betting on a rebound for this year's underperformers. The MFS Meridian Funds - Contrarian Value Fund acquired Thermo Fisher Scientific and Becton Dickinson in early summer, viewing them as undervalued opportunities.